Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
40.36
-0.46 (-1.13%)
Sep 5, 2025, 9:44 AM HKT

HKG:2591 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Net Income
-174.69-733.38
Depreciation & Amortization
16.7619.54
Other Amortization
0.170.1
Loss (Gain) From Sale of Assets
0.3-
Loss (Gain) From Sale of Investments
-0.19-1.13
Stock-Based Compensation
16.04538.9
Other Operating Activities
-12.58-8.43
Change in Inventory
-25.590.23
Change in Accounts Payable
2.7115.64
Change in Other Net Operating Assets
14.463.92
Operating Cash Flow
-162.62-164.6
Capital Expenditures
-3.95-12.05
Sale (Purchase) of Intangibles
-0.38-0.15
Investment in Securities
280.28-145.02
Investing Cash Flow
275.95-157.21
Short-Term Debt Issued
9.91
Total Debt Issued
9.91
Short-Term Debt Repaid
-1-1
Long-Term Debt Repaid
-0.81-4.45
Total Debt Repaid
-1.81-5.45
Net Debt Issued (Repaid)
8.1-4.45
Issuance of Common Stock
250367.81
Other Financing Activities
-3.26-11.66
Financing Cash Flow
254.84351.71
Foreign Exchange Rate Adjustments
0.70.71
Net Cash Flow
368.8730.61
Free Cash Flow
-166.57-176.64
Free Cash Flow Per Share
-0.40-0.46
Cash Interest Paid
0.872.32
Levered Free Cash Flow
-95.73-
Unlevered Free Cash Flow
-95.18-
Change in Working Capital
-8.4119.79
Source: S&P Global Market Intelligence. Standard template. Financial Sources.